Julian Baker, 10% Owner at Mirati Therapeutics, Inc. (MRTX), sold 979,388 shares at $9.40 ($9.2M) on 2016-06-09, disclosed to the SEC on 2016-06-09.
Open-market sale of $9.2M MRTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.44 | 16,493 | $156K | 1.7% |
| 2 | $9.44 | 275,506 | $2.6M | 28.2% |
| 3 | $9.44 | 4,201 | $40K | 0.4% |
| 4 | $9.21 | 147,529 | $1.4M | 14.7% |
| 5 | $9.21 | 2,154 | $20K | 0.2% |
| 6 | $9.21 | 8,417 |
| $78K |
| 0.8% |
| 7 | $9.40 | 5,111 | $48K | 0.5% |
| 8 | $9.40 | 349,919 | $3.3M | 35.7% |
| 9 | $9.56 | 2,318 | $22K | 0.2% |
| 10 | $9.56 | 9,056 | $87K | 0.9% |
| 11 | $9.56 | 158,684 | $1.5M | 16.5% |
| Total | $9.41 avg | 979,388 | $9.2M | 100% |
| Filing → |
| MDGL | BUY | 2023-11-15 | $15.6M | — | Filing → |
| BCEL | SELL | 2023-10-23 | $211K | — | Filing → |
| IGMS | BUY | 2023-06-28 | $45.0M | — | Filing → |